心脏骤停的药理学管理
Amandeep Singh1, Megan Heeney1, Martha E Montgomery1
1Alameda Health System, Highland Hospital Emergency Department, 1411 East 31st Street, Oakland, CA 94602, USA.
Cardiology clinics
|April 17, 2024
概括
本综述阐明了用于心脏骤停护理的药物的有效性,包括上腺素,血管压素-类固醇-上腺素,阿米奥达龙和利多卡因. 它还检查了其他药物,如,碳酸,,氨酸,β抑制剂和血栓抑制剂.
科学领域:
- 紧急医疗 紧急医疗
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心脏骤停期间药理干预的有效性仍然是持续辩论的主题.
- 最近的研究已经开始对各种药物在心脏骤停管理中的有效性提供更清晰的见解.
研究的目的:
- 审查目前关于心脏骤停中使用关键药物的有效性的证据.
- 讨论血管压缩剂,抗心律失常药物和其他支持性药物在复苏工作中的作用.
主要方法:
- 系统审查最近 (过去5年) 关于心脏骤停药疗的文献.
- 对上腺素,血管压素-类固醇-上腺素,阿米奥达龙和利多卡因的证据分析.
- 评估,碳酸,,氨酸,β抑制剂和血栓抑制剂的功效.
主要成果:
- 证据正在出现,以澄清上腺素和组合疗法的有效性.
- 像阿米奥达龙和利多卡因这样的抗节律药物已经确立了角色.
- 辅助药物和针对耐火节奏或特定病因的特定药物的作用正在被定义.
结论:
- 心脏骤停的药理管理正在发展,特定的药物显示不同程度的有效性.
- 证据支持使用某些血管压缩剂和抗失常药,而其他药物的作用需要进一步调查.
- 根据逮捕特征和可疑原因量身定制药物治疗对于改善结果至关重要.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
577
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
577
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:30Adrenergic Agonists: Therapeutic Uses
770
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
770
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
741
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
741
01:18Drug Delivery: Enteral Route
428
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
428
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
498
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
498